
Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins Acquisition offers customers worldwide a single point of access for cGMP cell culture solutions for biopharmaceuticals, and cell and gene therapies
News Release
March 22, 2022
Print
TOKYO, March 23, 2022 - FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for life science research, bioproduction, and cell therapy manufacturing, will acquire Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. Terms of the deal were not disclosed.
Shenandoah Biotechnology is a privately held company located in Warminster, Pennsylvania, that manufactures recombinant proteins including cytokines and growth factors. Shenandoah Biotechnology recently launched their CTG Grade line of cytokines and growth factors that are manufactured according to cGMP guidelines in the Company's new state-of-the-art, ISO 9001:2015 certified facility.
The use of cGMP manufactured products smooths the transition of biological therapies from preclinical to clinical phases.
At Fujifilm, our goal has always been to bring new value to society through the creation of innovative technologies, products and services, said Teiichi Goto, president and chief executive officer, representative director of FUJIFILM Corporation. The acquisition of Shenandoah Biotechnology marks an important milestone for us to establish a leading position as a partner for pharmaceutical customers in the rapidly-growing market of advanced therapy. Fujifilm will, by maximizing our group synergy, continue to expand Life Sciences Business while contributing to the creation of new therapies that fulfill unmet medical needs.
FUJIFILM Irvine Scientific is committed to helping customers bring advanced therapies to market faster, and to use innovation to make therapies more accessible, said Yutaka Yamaguchi, chairman and chief executive officer, FUJIFILM Irvine Scientific. Shenandoah Biotechnology's portfolio of recombinant proteins complement our advanced cell culture solutions and expertise in bioprocessing, providing our collective customers a single point of access for their life science research, discovery, and cell and gene therapy needs. This acquisition will be an important step toward achieving sales target of 100 billion yen (about 850 million USD*1) in Fujifilm's Life Sciences Business by FY2025.
*1 At an exchange rate of 1 USD = 118 JPY on March 23, 2022.
Yamaguchi added, The team at Shenandoah Biotechnology has years of proven experience in supplying the life science industry with high quality recombinant proteins at scale. We are excited to welcome all members of their talented team to the Fujifilm family, and look forward to what we can achieve together.
At Shenandoah Biotechnology, our vision is to provide a superior and affordable source of recombinant proteins to the drug discovery, life science research, and cell and gene therapy markets. We are pleased to join FUJIFILM Irvine Scientific given their experience with manufacturing ancillary materials for cell and gene therapy and commitment to providing high quality products and service to customers, said Pamela De Lacy, president, Shenandoah Biotechnology. We look forward to working with the team at FUJIFILM Irvine Scientific and continuing to build on our success.
The deal is expected to close later this month.
About Recombinant Proteins:
Recombinant proteins are used in a variety of life science applications. They are made by cloning engineered DNA into expression systems ( cell factories ) for the purpose of large-scale production of proteins of interest. Specific types of recombinant proteins such as growth factors and cytokines are essential for cell therapy, gene therapy and regenerative medicine in the areas of research, development and manufacturing. Growth factors and cytokines are important drivers of many cellular processes such as cell proliferation, growth, differentiation and cell signaling.
FUJIFILM Irvine Scientific www.irvinesci.com/
FUJIFILM Irvine Scientific, Inc., is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivaled service and quality to scientists working in biopharmaceuticals, cell therapy, and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. FUJIFILM Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA, and Tokyo, Japan. The company's consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 50 years, FUJIFILM Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services. FUJIFILM Irvine Scientific, Inc. is a subsidiary of FUJIFILM Holdings America Corporation reporting to FUJIFILM Holdings Corporation.
FUJIFILM Holdings Corporation holdings.fujifilm.com/en
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions, and imaging. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging te
More from Fujifilm
31/05/2023
Ratingen, June 1, 2023 - FUJIFILM Europe GmbH today launches Print Experience Ce...
26/05/2023
Sustainable savings
Going the extra mile at FESPA 2023, Fujifilm has fitted ea...
24/05/2023
FUJIFILM X-S20
When the XC15-45mmF3.5-5.6 OIS PZ is mounted
The X-S20 is equipped with the back-illuminated 26.1MP sensor X-Trans CMOS 4 *3 and the high-spe...
24/05/2023
XF8mmF3.5 R WR
When mounted on the mirrorless digital camera FUJIFILM X-S20
The XF8mmF3.5 R WR is an UWA lens, consisting of 12 lens elements, including thr...
24/05/2023
Controlling a camera remotely with the XApp
Transferring pictures saved in a camera with the XApp
Fujifilm has worked on broadening the appeals of photography...
23/05/2023
Fujifilm today announces the launch of the Acuity Prime Hybrid printer, showcased for the first time on its stand (B10, Hall A1) at FESPA 2023. This ground-brea...
22/05/2023
Mark Mashiter - Soyang Europe Managing Director
He adds:
We already support a ...
10/05/2023
Learn more
Contact
Media contact
FUJIFILM Holdings Corporation
Corporate ...
09/05/2023
The new printer, which has been installed at its 20,000 square metre site in Ja ...
04/05/2023
Fujifilm Europe today announces more details about its new digital flexible pack...
04/05/2023
Manuel Schrutt, Head of Packaging, EMEA says:
At Fujifilm, we are constantly lo...
02/05/2023
Moving from solvent to water-based cleaning
Fujifilm's old pot cleaning pr...
27/04/2023
ANTWERP, Belgium - April 27, 2023 - FUJIFILM Corporation (President and CEO, Rep...
27/04/2023
Daren Hollins, Head of Procurement at Nuneaton Signs said the company sought a new flatbed printer to speed up the production of its signs and manufactured good...
26/04/2023
Fujifilm UK, dedicated to innovating towards a healthier world and sustainable s...
17/04/2023
* This is not the image of the final product. The roadmap is as of April, 2023. ...
14/04/2023
Best of the Best Award logo
Red Dot Design Award 2023 logo
23 Red Dot Desig...
13/04/2023
Fujifilm today announces that it has formed a strategic partnership with Germany...
12/04/2023
FUJIFILM SX1600
Long-range cameras are widely used in long-distance surveillance applications at international borders, ports, airports, etc. They are also sta...
12/04/2023
An example of what a workflow looks like in the product
Following the announcem...
04/04/2023
Family-run wide format business A1 Signs has become the first company in the wor...
03/04/2023
Fujifilm today announces that its Revoria and ApeosPro C Series toner presses ar...
03/04/2023
NHS England, in partnership with Fujifilm UK, has today launched a national phot...
21/03/2023
Fujifilm will exhibit its extensive portfolio of analogue and digital packaging ...
21/03/2023
The recently announced partnership represents a shared commitment to innovation between Fujifilm and Josero, a Soyang Europe business Josero, a hardware suppl...
07/03/2023
Fujifilm has today confirmed that the Acuity Prime L flatbed printer is now commercially available. The printer, which was unveiled at FESPA 2022, is a larger v...
02/03/2023
RATINGEN, Germany, March 2, 2023 - FUJIFILM Europe GmbH, Imaging Division, has launched the new INSTAX MINI 12 Instant Camera (hereinafter MINI 12 ). Built wit...
02/03/2023
FUJIFILM Europe GmbH, Imaging Division, has announced the launch of Fujifilm's free, downloadable INSTAX UP! Smartphone App (hereinafter INSTAX UP!), design...
28/02/2023
Fujifilm today announces the launch of a new range of Luxel thermal platesetters...
13/02/2023
Fujifilm announces first global beta site for its Acuity Ultra Hybrid LED
February 13, 2023
Print
Echo House in Surbiton, UK will trial the new superwide ...
09/02/2023
A journey into food culture with the new issue of Fujifilms Women4Women magazine Eating nourishes the body, but cooking nourishes the soul' Fatma Top u A...
09/02/2023
Fujifilm announces the commercial availability of its ApeosPro C series of light...
08/02/2023
FUJIFILM Holdings to donate 50 million yen [approx. 355,000] for people affecte...
08/02/2023
Stepping up on sustainability
February 8, 2023
Print
The FUJIFILM Speciality Ink Systems award-winning factory in Broadstairs, UK, manufactures high perfo...
06/02/2023
Fujifilm Expands its RxD Inkjet Pigment Dispersions Colour Range
February 6, 2023
Print
New Orange, Green and Violet colours enable the formulation of ink...
23/01/2023
Fujifilm UK looks to boost wide format market presence with the appointment of n...
19/01/2023
Fujifilm Europe supports World Cancer Day
January 19, 2023
Print
Fujifilm Europe has announced its partnership with World Cancer Day, an initiative led by...
10/01/2023
Fujifilm continues to expand packaging team with new recruits in Italy and Spain New appointments will help to boost Fujifilm's packaging product sales ac...
06/01/2023
FUJIFILM Cellular Dynamics Announces License Agreement with Novo Nordisk for the...
06/01/2023
Thousands of photos from across Europe capture precious and special memories for...
05/01/2023
Fujifilm Announces Addition of Splatoon 3 and Other Unique Features in the Upda...
26/12/2022
Fujifilm and Utilization of Carbon Dioxide Institute sign a joint research agree...
21/12/2022
Fujifilm to open FUJIFILM Creative Village in Tokyo The new base for Fujifilm Group's design and IT development Designers and IT engineers exerting their ...
19/12/2022
Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the ...